Today, the BSE Sensex saw a 500 point fall and cracked in proportion to other international markets.

While pointing out on the U-turn taken by the stock market, technical analyst, Vishwas Agarwal stated that Indian stock market was faultily affected today because of reduction in worldwide markets and panic selling.

Saturday’s RIL result is crucial to hoard the persuasions now. Any optimistic news from RIL can ease the market to some extent.

But one thing is obvious that stock market mood has turned very cautious now and people are feeling insecure. So they will make an effort to go out with minimal losses in their place before buying more at existing levels.

Broking house, P-Sec recommended hold rating on Thermax.

P-Sec report on Thermax:

Thermax reported a growth of 107% yoy and a bottom line growth of 103% yoy. The results bettered our expectations with a big margin, the EBITDA margins sank by 38 bps yoy. The management had given a rich guidance of 40% yoy growth for FY08 and have maintained there position of stable to better margins.

The current order book stands at Rs. 36.72bln (0up by 66%yoy) that is 1.42x net sales of FY07 offering visibility for future growth.

Sharekhan Research maintained purchase rating on Sun Pharmaceutical Industries with target price of Rs 1287. At current market price Rs 965, stock valued at 21.6x FY2008E and 18.1xFY2009E fully diluted earnings.

Result highlights:

Emkay Research report on GTL:

According to technical Analyst, Sudarshan Sukhani the investors should stay away from

Finquest Research is expecting Kewal Kiran Clothing and rec